Kopran Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Mridula Somani, was filed 08 Jan 2025.
Kopran Limited: what insiders have been doing
Kopran Limited belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). Kopran Limited has had no insider filing for more than a year; the last one goes back to 8 January 2025.
Elsewhere in the same sector, our signals recently picked up insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 1,764,750 sharesEquity SharesSEBI:1d2bb6b1f8c49fddbd6f14cd1cec4e0fbc7016d8Canonical exit: 18 Mar 2025 (T+90)
- 1,764,750 sharesEquity SharesSEBI:1a86ea50fb9dd06bc3e8be0784255a68f60de4e3Canonical exit: 18 Mar 2025 (T+90)
- 289,000 sharesEquity SharesSEBI:16f7432b1914bc8517bdb2bdf720d667204ce8f2Canonical exit: 31 Aug 2023 (T+90)
- 28,500 shares@ ₹107.9330.5% of flowEquity SharesSEBI:7deb8d4ae36f5686cb141fdd570315fd0d8c6d63Canonical exit: 29 Jun 2023 (T+90)
- 65,500 shares@ ₹107.0869.5% of flowEquity SharesSEBI:d2f351587681749a34b1cd899b640eaa2dbfb920Canonical exit: 29 Jun 2023 (T+90)
- 270,500 sharesEquity SharesSEBI:bd8fcb55afd0ce6923e1c49456f94f380b00b2cfCanonical exit: 21 Apr 2023 (T+90)
- 11,000 shares@ ₹135.0650.0% of flowEquity SharesSEBI:e968c39f3d5e206e3fb2fe676a0254e57e564f4eCanonical exit: 19 Feb 2023 (T+90)
- 10,000 shares@ ₹149.2050.0% of flowEquity SharesSEBI:0b05b9dc7539def83a9596f742e79d87c51c67a4Canonical exit: 15 Feb 2023 (T+90)
8 of 8 declarations
About Kopran Limited
Kopran Limited is a company operating in the healthcare and pharmaceutical sector, specializing in the manufacture of pharmaceutical products. It is listed on the XBOM.
